Skip to content
DeepViews

The Cooper Companies, Inc. Common Stock (COO) — Analysis Summary

The Cooper Companies, Inc. Common Stock (COO) has a market cap of $10.56B with year-over-year revenue growth of +5.1%. Net margin stands at 9.2%. The stock trades at a P/E ratio of 18.5.

Key Takeaways

  • Revenue changed +5.1% year-over-year
  • Net margin of 9.2%
  • P/E ratio of 18.5

Compared to other companies in the OPHTHALMIC GOODS sector, COO posted revenue growth of +5.1% and trades at a P/E of 18.5.

[XNAS]

The Cooper Companies, Inc. Common Stock (COO)

$55.55

PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR

Market Cap
$10.56B
Enterprise Value
$12.32B
P/E Ratio
18.5
Div Yield
0.11%
EV/EBITDA
13.3
Company Profile
About
About The Cooper Companies, Inc. Common Stock

CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.

Sector

OPHTHALMIC GOODS

Employees

15,000

Headquarters

SAN RAMON, CA

Exchange

XNAS

Website
Source: Polygon.io
Score
Competitive Moat
Competitive Moat
64
Narrow Moat

Systematic competitive advantage assessment based on 4yr data

This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.

Market Signals
Valuation
Earnings
Insider Activity
Insider Filing Activity

First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.

Loading SEC insider filing activity...
Superinvestors
Financial Health
Financial Health

Capital Structure

Total Equity$8328.40M
Total Debt$1916.10M
Debt-to-Equity0.23
Cash & Equivalents$154.70M

Cash Flow

Operating Cash Flow$1033.30M
Free Cash Flow$678.00M
FCF Margin16.00%
P/FCF Ratio15.58
Source: Polygon.io · SEC EDGAR
Dividends
Dividends

Annual Dividend/Share

$0.06

Dividend Yield

0.11%

Semi-Annual
Last Ex-Date: 2023-07-26

Dividend History

2023-07-26
CD$0.0300
2023-01-20
CD$0.0300
2022-07-26
CD$0.0300
2022-01-20
CD$0.0300
Source: Polygon.io
Recent News
Recent News

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.